Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Double-Blind, Randomized Controlled Trial of Quetiapine as a Treatment for Delirium in Critically Ill Children

NCT03572257 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT03572257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03572257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Double-Blind, Randomized Controlled Trial of Quetiapine as a Treatment for Delirium in Critically Ill Children
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2/3
Overall status
Withdrawn
Start date
April 15, 2019
Completion date
March 2, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium